ProText Mobility, Inc. (TXTM)
0.0034
0.00 (0.00%)
USD |
OTCM |
Jan 20, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 5.864M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 183.3% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 96.45% |
Profile
| ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. It has license to develop Phytofare, which is a bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract. The company was founded by Ahmed Jamaloodeen & Dylon Du Plooy on September 5, 2001 and is headquartered in Fort Lauderdale, FL. |
| URL | http://www.sentryparentalcontrols.com |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. It has license to develop Phytofare, which is a bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract. The company was founded by Ahmed Jamaloodeen & Dylon Du Plooy on September 5, 2001 and is headquartered in Fort Lauderdale, FL. |
| URL | http://www.sentryparentalcontrols.com |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |